Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11451
CALL
PepGen
PEPG
$167M
| $120K | ﹤0.01% |
18,500
-2,900
| -14% | -$15.1K |
|
11452
PUT
MidCap Financial Investment
MFIC
$800M
| $120K | ﹤0.01% |
+10,500
| New | +$125K |
|
|
HFRO
11453
Highland Opportunities and Income Fund
HFRO
$406M
| $120K | ﹤0.01% |
+20,046
| New | +$126K |
|
11454
CALL
DocGo
DCGO
$61.7M
| $119K | ﹤0.01% |
136,100
+123,500
| +980% | +$132K |
|
11455
CALL
Mitek Systems
MITK
$759M
| $119K | ﹤0.01% |
11,300
-79,700
| -88% | -$753K |
|
|
SMUP
11456
T-REX 2X Long SMR Daily Target ETF
SMUP
$11.5M
| $119K | ﹤0.01% |
+5,100
| New | +$847K |
|
11457
Tilly's
TLYS
$126M
| $119K | ﹤0.01% |
59,677
-5,049
| -8% | -$8.27K |
|
11458
CALL
Immatics
IMTX
$1.29B
| $119K | ﹤0.01% |
11,300
-25,300
| -69% | -$255K |
|
11459
CALL
908 Devices
MASS
$341M
| $119K | ﹤0.01% |
22,600
-17,300
| -43% | -$121K |
|
|
GLO
11460
Clough Global Opportunities Fund
GLO
$255M
| $119K | ﹤0.01% |
+20,950
| New | +$119K |
|
11461
Banco Bradesco
BBDO
$34.3B
| $119K | ﹤0.01% |
41,297
-22,961
| -36% | -$68.5K |
|
11462
CALL
Blink Charging
BLNK
$77.6M
| $118K | ﹤0.01% |
177,400
-128,300
| -42% | -$186K |
|
11463
ABVC BioPharma
ABVC
$26.5M
| $118K | ﹤0.01% |
55,543
+39,879
| +255% | +$107K |
|
11464
Xerox
XRX
$424M
| $118K | ﹤0.01% |
49,836
-1,179,393
| -96% | -$3.49M |
|
11465
United States 12 Month Natural Gas Fund
UNL
$13.1M
| $118K | ﹤0.01% |
15,974
-12,057
| -43% | -$96.1K |
|
11466
CALL
Runway Growth Finance
RWAY
$254M
| $118K | ﹤0.01% |
+13,200
| New | +$125K |
|
11467
BioCardia
BCDA
$14.1M
| $118K | ﹤0.01% |
+94,247
| New | +$128K |
|
11468
PUT
4D Molecular Therapeutics
FDMT
$552M
| $118K | ﹤0.01% |
15,700
+3,100
| +25% | +$31.4K |
|
11469
CALL
Korro Bio
KRRO
$178M
| $118K | ﹤0.01% |
+14,700
| New | +$344K |
|
11470
PUT
Good Times Restaurants
GTIM
$15M
| $118K | ﹤0.01% |
+97,200
| New | +$136K |
|
|
IMDX
11471
Insight Molecular Diagnostics
IMDX
$155M
| $117K | ﹤0.01% |
15,647
+3,860
| +33% | +$21.8K |
|
|
KAZR
11472
Skyline Builders Group
KAZR
$52.8M
| $117K | ﹤0.01% |
+39,876
| New | +$119K |
|
|
EFT
11473
Eaton Vance Floating-Rate Income Trust
EFT
$287M
| $117K | ﹤0.01% |
+10,340
| New | +$118K |
|
11474
CALL
Satellogic
SATL
$747M
| $117K | ﹤0.01% |
62,400
+46,600
| +295% | +$101K |
|
11475
Coya Therapeutics
COYA
$107M
| $116K | ﹤0.01% |
20,083
-45,157
| -69% | -$275K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.